ACAD Insider Trading

Insider Ownership Percentage: 27.50%
Insider Buying (Last 12 Months): $5,312,036.73
Insider Selling (Last 12 Months): $5,743,891.04

ACADIA Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at ACADIA Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ACADIA Pharmaceuticals Share Price & Price History

Current Price: $23.55
Price Change: Price Increase of +0.15 (0.64%)
As of 09/22/2023 12:02 PM ET

This chart shows the closing price history over time for ACAD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Fox Couldn't Air my #1 A.I. Pick - Get it Here.
50-year Wall Street Insider Marc Chaikin got invited onto Fox News to talk about A.I. - Here's what he couldn't say on television. More here.
More here.

ACADIA Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/15/2023James KiharaInsiderSell2,000$25.88$51,760.0010,778View SEC Filing Icon  
8/21/2023Mark C SchneyerCFOSell10,000$29.00$290,000.0015,682View SEC Filing Icon  
7/14/2023Stephen R. DavisCEOSell100,000$30.04$3,004,000.0036,695View SEC Filing Icon  
7/11/2023Stephen R. DavisCEOSell16,498$25.00$412,450.0091,799View SEC Filing Icon  
6/15/2023James KiharaInsiderSell2,000$24.15$48,300.009,144View SEC Filing Icon  
6/12/2023Laura BregeDirectorSell4,500$24.87$111,915.0013,502View SEC Filing Icon  
6/8/2023Mark C SchneyerCFOSell974$25.02$24,369.4822,824View SEC Filing Icon  
5/23/2023Bros. Advisors Lp BakerDirectorBuy209,053$25.41$5,312,036.7338,811,515View SEC Filing Icon  
5/17/2023Brendan TeehanCOOSell14,869$22.50$334,552.5024,356View SEC Filing Icon  
5/17/2023James KiharaInsiderSell5,947$22.50$133,807.5011,144View SEC Filing Icon  
5/17/2023Mark C SchneyerCFOSell15,310$22.50$344,475.0021,905View SEC Filing Icon  
5/1/2023Austin D KimEVPSell917$21.18$19,422.0625,513View SEC Filing Icon  
5/1/2023Brendan TeehanCOOSell548$21.18$11,606.649,487View SEC Filing Icon  
5/1/2023Stephen R. DavisCEOSell7,806$21.18$165,331.08108,297View SEC Filing Icon  
4/10/2023James KiharaInsiderSell523$18.14$9,487.225,197View SEC Filing Icon  
4/6/2023Austin D KimEVPSell1,456$18.16$26,440.9623,425View SEC Filing Icon  
4/6/2023Brendan TeehanCOOSell1,751$18.16$31,798.168,468View SEC Filing Icon  
4/6/2023James KiharaInsiderSell701$18.16$12,730.164,231View SEC Filing Icon  
4/6/2023Mark C SchneyerCFOSell1,916$18.16$34,794.567,477View SEC Filing Icon  
4/6/2023Stephen R. DavisCEOSell8,582$18.16$155,849.12100,478View SEC Filing Icon  
2/24/2023Austin D KimEVPSell803$18.78$15,080.3420,108View SEC Filing Icon  
2/24/2023Brendan TeehanCOOSell461$18.78$8,657.585,195View SEC Filing Icon  
2/24/2023James KiharaInsiderSell350$18.78$6,573.002,923View SEC Filing Icon  
2/24/2023Mark C SchneyerCFOSell577$18.78$10,836.064,118View SEC Filing Icon  
2/24/2023Stephen R. DavisCEOSell3,851$18.78$72,321.7891,727View SEC Filing Icon  
1/12/2023Laura BregeDirectorSell12,500$18.25$228,125.00View SEC Filing Icon  
1/9/2023Austin D KimEVPSell589$17.13$10,089.5718,697View SEC Filing Icon  
1/9/2023Brendan TeehanCOOSell532$17.13$9,113.164,549View SEC Filing Icon  
1/9/2023Stephen R. DavisCEOSell3,904$17.13$66,875.5284,633View SEC Filing Icon  
11/21/2022Srdjan R StankovicPresidentSell1,847$15.07$27,834.2961,234View SEC Filing Icon  
10/15/2022Srdjan R StankovicPresidentSell1,326$15.81$20,964.0656,831View SEC Filing Icon  
10/15/2022Stephen R. DavisCEOSell2,804$15.81$44,331.2479,009View SEC Filing Icon  
6/9/2022Mark C SchneyerCFOSell653$17.91$11,695.233,342View SEC Filing Icon  
5/2/2022Austin D KimEVPSell894$18.18$16,252.9216,742View SEC Filing Icon  
5/2/2022Brendan TeehanCOOSell552$18.18$10,035.363,437View SEC Filing Icon  
5/2/2022Srdjan R StankovicPresidentSell2,865$18.18$52,085.7055,188View SEC Filing Icon  
5/2/2022Stephen R. DavisCEOSell5,483$18.18$99,680.9475,875View SEC Filing Icon  
4/8/2022James KiharainsiderSell1,025$27.05$27,726.252,433View SEC Filing Icon  
2/23/2022Austin D KimEVPSell782$23.80$18,611.60View SEC Filing Icon  
2/23/2022Brendan TeehanCOOSell472$23.80$11,233.60View SEC Filing Icon  
2/23/2022James KiharaInsiderSell359$23.80$8,544.20View SEC Filing Icon  
2/23/2022Srdjan R StankovicPresidentSell1,501$23.80$35,723.80View SEC Filing Icon  
2/23/2022Stephen R. DavisCEOSell3,928$23.80$93,486.40View SEC Filing Icon  
11/22/2021Srdjan R StankovicPresidentSell2,803$19.01$53,285.03View SEC Filing Icon  
10/18/2021Srdjan R StankovicPresidentSell1,338$17.41$23,294.58View SEC Filing Icon  
10/18/2021Stephen R. DavisCEOSell2,963$17.41$51,585.83View SEC Filing Icon  
4/30/2021Austin D. KimEVPSell1,054$20.33$21,427.82View SEC Filing Icon  
4/30/2021Elena RidloffCFOSell1,032$20.33$20,980.5611,585View SEC Filing Icon  
4/30/2021Srdjan R. StankovicPresidentSell4,230$20.33$85,995.9040,664View SEC Filing Icon  
4/30/2021Stephen R. DavisCEOSell7,850$20.33$159,590.50View SEC Filing Icon  
2/4/2021Austin D KimEVPSell2,107$50.61$106,635.2712,018View SEC Filing Icon  
2/4/2021Elena RidloffCFOSell2,051$50.61$103,801.1110,391View SEC Filing Icon  
2/4/2021Srdjan R StankovicPresidentSell8,429$50.61$426,591.6939,478View SEC Filing Icon  
2/4/2021Stephen R. DavisCEOSell14,195$50.61$718,408.9543,059View SEC Filing Icon  
1/12/2021Srdjan R StankovicPresidentSell700$55.01$38,507.0020,947View SEC Filing Icon  
1/8/2021Srdjan R StankovicPresidentSell29,733$55.22$1,641,856.2621,972View SEC Filing Icon  
1/6/2021Elena RidloffCFOSell1,016$53.34$54,193.444,917View SEC Filing Icon  
1/6/2021Michael J YangEVPSell1,120$53.34$59,740.809,179View SEC Filing Icon  
1/6/2021Srdjan R StankovicPresidentSell1,725$53.34$92,011.5021,972View SEC Filing Icon  
1/6/2021Stephen R. DavisCEOSell3,484$53.34$185,836.56View SEC Filing Icon  
11/20/2020Srdjan R StankovicPresidentSell2,728$53.50$145,948.0019,256View SEC Filing Icon  
10/27/2020Austin D. KimEVPSell8,750$45.10$394,625.00View SEC Filing Icon  
10/16/2020Michael J YangEVPSell1,247$42.56$53,072.327,704View SEC Filing Icon  
10/16/2020Srdjan R StankovicPresidentSell1,297$42.56$55,200.3214,303View SEC Filing Icon  
10/16/2020Stephen R. DavisCEOSell2,960$42.56$125,977.6017,746View SEC Filing Icon  
See Full Table
3 AI Stocks Set to Soar in 2023
Eric Fry just released the names of 3 AI-driven stocks he believes every investor should own, even in these crazy markets — one stock is up over 100% since the beginning of 2023.

Click here to learn their names – FOR FREE.
>>>

SEC Filings (Institutional Ownership Changes) for ACADIA Pharmaceuticals (NASDAQ:ACAD)

96.29% of ACADIA Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ACAD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ACADIA Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/21/2023Barclays PLC189,540$4.54M0.0%+14.4%0.116%Search for SEC Filing on Google Icon
8/22/2023Virginia Retirement Systems ET AL57,400$1.38M0.0%N/A0.035%Search for SEC Filing on Google Icon
8/21/2023California State Teachers Retirement System140,237$3.36M0.0%-7.4%0.086%Search for SEC Filing on Google Icon
8/21/2023Osaic Holdings Inc.31,909$0.77M0.0%+29.3%0.019%Search for SEC Filing on Google Icon
8/16/2023Nuveen Asset Management LLC690,966$16.55M0.0%+32.6%0.422%Search for SEC Filing on Google Icon
8/16/2023Neo Ivy Capital Management36,483$0.87M0.5%N/A0.022%Search for SEC Filing on Google Icon
8/15/2023Alliancebernstein L.P.192,111$4.60M0.0%+26.2%0.117%Search for SEC Filing on Google Icon
8/15/2023Wells Fargo & Company MN186,957$4.48M0.0%+4.3%0.114%Search for SEC Filing on Google Icon
8/15/2023Natixis Advisors L.P.25,087$0.60M0.0%+79.5%0.015%Search for SEC Filing on Google Icon
8/15/2023Woodline Partners LP830,355$19.89M0.2%+92.7%0.507%Search for SEC Filing on Google Icon
8/15/2023Y Intercept Hong Kong Ltd19,959$0.48M0.1%-29.1%0.012%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.1,273,424$30.50M0.0%+30.0%0.778%Search for SEC Filing on Google Icon
8/15/2023Captrust Financial Advisors63,769$1.53M0.0%N/A0.039%Search for SEC Filing on Google Icon
8/15/2023Lazard Asset Management LLC4,125$98K0.0%+35.8%0.003%Search for SEC Filing on Google Icon
8/15/2023Point72 Asset Management L.P.891,926$21.36M0.1%+35.2%0.545%Search for SEC Filing on Google Icon
8/15/2023Point72 Middle East FZE25,356$0.61M0.0%N/A0.015%Search for SEC Filing on Google Icon
8/15/2023Royal Bank of Canada52,522$1.26M0.0%+6.0%0.032%Search for SEC Filing on Google Icon
8/15/2023Rockefeller Capital Management L.P.404,289$9.68M0.0%-15.9%0.247%Search for SEC Filing on Google Icon
8/15/2023Seven Eight Capital LP53,724$1.29M0.2%N/A0.033%Search for SEC Filing on Google Icon
8/15/2023HighVista Strategies LLC28,791$0.69M0.3%-48.2%0.018%Search for SEC Filing on Google Icon
8/14/2023PDT Partners LLC97,505$2.34M0.3%-41.6%0.060%Search for SEC Filing on Google Icon
8/14/2023Ergoteles LLC52,188$1.25M0.1%+44.5%0.032%Search for SEC Filing on Google Icon
8/14/2023State of Wyoming4,625$0.11M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/14/2023Tower Research Capital LLC TRC 11,273$0.27M0.0%+218.8%0.007%Search for SEC Filing on Google Icon
8/14/2023Schonfeld Strategic Advisors LLC74,667$1.79M0.0%N/A0.046%Search for SEC Filing on Google Icon
8/14/2023Penn Capital Management Company LLC187,003$4.48M0.4%N/A0.114%Search for SEC Filing on Google Icon
8/14/2023Marshall Wace LLP24,852$0.60M0.0%N/A0.015%Search for SEC Filing on Google Icon
8/14/2023State of Wisconsin Investment Board105,732$2.53M0.0%-11.0%0.065%Search for SEC Filing on Google Icon
8/14/2023State Street Corp5,420,318$129.82M0.0%-3.0%3.311%Search for SEC Filing on Google Icon
8/14/2023Capital Fund Management S.A.231,461$5.54M0.0%+43.9%0.141%Search for SEC Filing on Google Icon
8/14/2023Frontier Capital Management Co. LLC649,710$15.56M0.1%+21.7%0.397%Search for SEC Filing on Google Icon
8/14/2023Nuveen Asset Management LLC690,966$16.55M0.0%+32.6%0.422%Search for SEC Filing on Google Icon
8/14/2023Thrivent Financial for Lutherans206,656$4.95M0.0%-22.5%0.126%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC130,800$3.13M0.0%+11.0%0.080%Search for SEC Filing on Google Icon
8/11/2023Credit Suisse AG174,664$4.18M0.0%-14.7%0.107%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.10,039,501$240.45M0.0%+1.7%6.132%Search for SEC Filing on Google Icon
8/11/2023Ameritas Investment Partners Inc.10,007$0.24M0.0%+6.6%0.006%Search for SEC Filing on Google Icon
8/11/2023Panagora Asset Management Inc.675,161$16.17M0.1%-7.3%0.412%Search for SEC Filing on Google Icon
8/11/2023Campbell & CO Investment Adviser LLC15,619$0.37M0.1%N/A0.010%Search for SEC Filing on Google Icon
8/11/2023Kestra Advisory Services LLC8,403$0.20M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/11/2023State Board of Administration of Florida Retirement System34,401$0.82M0.0%-13.7%0.021%Search for SEC Filing on Google Icon
8/11/2023The Manufacturers Life Insurance Company 913,025$21.87M0.0%+4.7%0.558%Search for SEC Filing on Google Icon
8/11/2023Franklin Resources Inc.47,404$1.14M0.0%+53.8%0.029%Search for SEC Filing on Google Icon
8/11/2023Trexquant Investment LP157,084$3.76M0.1%+43.9%0.096%Search for SEC Filing on Google Icon
8/11/2023Guggenheim Capital LLC47,836$1.15M0.0%-6.1%0.029%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC2,494,338$59.74M0.0%+4.4%1.523%Search for SEC Filing on Google Icon
8/11/2023Sei Investments Co.26,967$0.65M0.0%+10.4%0.016%Search for SEC Filing on Google Icon
8/11/2023E Fund Management Co. Ltd.18,068$0.43M0.0%-4.2%0.011%Search for SEC Filing on Google Icon
8/11/2023JPMorgan Chase & Co.280,992$6.73M0.0%-82.3%0.172%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp1,163,122$27.86M0.0%-0.3%0.710%Search for SEC Filing on Google Icon
8/10/2023Osaic Holdings Inc.31,909$0.77M0.0%+29.3%0.019%Search for SEC Filing on Google Icon
8/10/2023Great West Life Assurance Co. Can33,666$0.81M0.0%+4.4%0.021%Search for SEC Filing on Google Icon
8/10/2023ProShare Advisors LLC26,284$0.63M0.0%+3.5%0.016%Search for SEC Filing on Google Icon
8/10/2023Profund Advisors LLC62,081$1.49M0.1%-1.1%0.038%Search for SEC Filing on Google Icon
8/10/2023Gabelli Funds LLC9,000$0.22M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/10/2023Edgestream Partners L.P.84,170$2.02M0.2%N/A0.051%Search for SEC Filing on Google Icon
8/10/2023Mirae Asset Global Investments Co. Ltd.74,819$1.79M0.0%-2.4%0.046%Search for SEC Filing on Google Icon
8/10/2023Russell Investments Group Ltd.336,774$8.07M0.0%+3.7%0.206%Search for SEC Filing on Google Icon
8/10/2023Jupiter Asset Management Ltd.1,271,284$30.45M0.3%-7.0%0.776%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.981,452$23.51M0.0%+1.3%0.599%Search for SEC Filing on Google Icon
8/10/2023Citigroup Inc.144,078$3.45M0.0%-48.3%0.088%Search for SEC Filing on Google Icon
8/9/2023Dimensional Fund Advisors LP102,341$2.45M0.0%-21.4%0.063%Search for SEC Filing on Google Icon
8/9/2023Cim Investment Management Inc.10,252$0.25M0.1%N/A0.006%Search for SEC Filing on Google Icon
8/9/2023BNP Paribas Arbitrage SNC297,423$7.12M0.0%+10.5%0.182%Search for SEC Filing on Google Icon
8/9/2023TD Asset Management Inc174,423$4.18M0.0%+49.2%0.107%Search for SEC Filing on Google Icon
8/9/2023Swiss National Bank247,304$5.92M0.0%-5.6%0.151%Search for SEC Filing on Google Icon
8/8/2023Rhumbline Advisers180,776$4.33M0.0%+4.0%0.110%Search for SEC Filing on Google Icon
8/8/2023International Biotechnology Trust PLC151,000$3.62M1.1%-30.1%0.092%Search for SEC Filing on Google Icon
8/7/2023Principal Financial Group Inc.63,182$1.51M0.0%-5.3%0.039%Search for SEC Filing on Google Icon
8/7/2023New York Life Investment Management LLC21,899$0.52M0.0%-12.0%0.013%Search for SEC Filing on Google Icon
8/4/2023Envestnet Asset Management Inc.92,517$2.22M0.0%+43.0%0.057%Search for SEC Filing on Google Icon
8/3/2023Los Angeles Capital Management LLC41,537$1M0.0%+63.2%0.026%Search for SEC Filing on Google Icon
8/3/2023Headlands Technologies LLC5,562$0.13M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/3/2023Barclays PLC189,540$4.54M0.0%+14.4%0.117%Search for SEC Filing on Google Icon
8/3/2023Mackenzie Financial Corp23,662$0.57M0.0%+77.4%0.015%Search for SEC Filing on Google Icon
8/3/2023Hussman Strategic Advisors Inc.62,000$1.49M0.3%-33.3%0.038%Search for SEC Filing on Google Icon
8/3/2023Van Hulzen Asset Management LLC28,890$0.69M0.1%-2.6%0.018%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp567,872$13.60M0.0%-0.8%0.349%Search for SEC Filing on Google Icon
8/3/2023Jackson Creek Investment Advisors LLC47,395$1.14M0.5%+6.7%0.029%Search for SEC Filing on Google Icon
8/3/2023Oppenheimer Asset Management Inc.25,404$0.61M0.0%+50.3%0.016%Search for SEC Filing on Google Icon
8/2/2023Nemes Rush Group LLC2,000$48K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/2/2023State of New Jersey Common Pension Fund D101,950$2.44M0.0%-16.7%0.063%Search for SEC Filing on Google Icon
8/2/2023Handelsbanken Fonder AB30,933$0.74M0.0%+21.6%0.019%Search for SEC Filing on Google Icon
8/1/2023Truist Financial Corp64,682$1.55M0.0%+45.9%0.040%Search for SEC Filing on Google Icon
8/1/2023Arizona State Retirement System31,897$0.76M0.0%-9.4%0.020%Search for SEC Filing on Google Icon
8/1/2023Cookson Peirce & Co. Inc.71,163$1.70M0.1%N/A0.044%Search for SEC Filing on Google Icon
7/31/2023LPL Financial LLC52,392$1.26M0.0%+12.2%0.032%Search for SEC Filing on Google Icon
7/31/2023Strs Ohio46,000$1.10M0.0%N/A0.028%Search for SEC Filing on Google Icon
7/28/2023First Republic Investment Management Inc.11,058$0.27M0.0%-23.8%0.007%Search for SEC Filing on Google Icon
7/28/2023Hohimer Wealth Management LLC17,883$0.43M0.1%-11.8%0.011%Search for SEC Filing on Google Icon
7/27/2023Victory Capital Management Inc.78,171$1.87M0.0%-0.5%0.048%Search for SEC Filing on Google Icon
7/25/2023Raymond James & Associates8,984$0.22M0.0%N/A0.006%Search for SEC Filing on Google Icon
7/25/2023DekaBank Deutsche Girozentrale90,000$2.14M0.0%+23.8%0.055%Search for SEC Filing on Google Icon
7/24/2023Allspring Global Investments Holdings LLC37,980$0.91M0.0%-57.3%0.023%Search for SEC Filing on Google Icon
7/24/2023Rice Hall James & Associates LLC886,453$21.23M1.2%-0.1%0.545%Search for SEC Filing on Google Icon
7/19/2023Teacher Retirement System of Texas30,809$0.74M0.0%-17.7%0.019%Search for SEC Filing on Google Icon
7/18/2023Diversified Trust Co27,168$0.65M0.0%-15.8%0.017%Search for SEC Filing on Google Icon
7/18/2023Allspring Global Investments Holdings LLC37,980$0.91M0.0%-57.3%0.023%Search for SEC Filing on Google Icon
7/10/2023SG Americas Securities LLC5,233$0.13M0.0%-96.6%0.003%Search for SEC Filing on Google Icon
7/10/2023DNB Asset Management AS12,141$0.29M0.0%N/A0.007%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ACADIA Pharmaceuticals logo
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company also develops Trofinetide, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome; Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-204 for the treatment of Alzheimer's disease psychosis; antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms. It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. The company was founded in 1993 and is headquartered in San Diego, California.
Read More on ACADIA Pharmaceuticals

Today's Range

Now: $23.55
Low: $23.48
High: $23.74

50 Day Range

MA: $28.05
Low: $23.40
High: $33.47

52 Week Range

Now: $23.55
Low: $13.73
High: $33.99

Volume

394,957 shs

Average Volume

1,514,116 shs

Market Capitalization

$3.86 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.57

Who are the company insiders with the largest holdings of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals' top insider investors include:
  1. Bros Advisors Lp Baker (Director)
  2. Stephen Davis (CEO)
  3. Srdjan R Stankovic (President)
  4. Austin D Kim (EVP)
  5. Brendan Teehan (COO)
  6. Mark C Schneyer (CFO)
  7. Laura Brege (Director)
  8. James Kihara (Insider)
Learn More about top insider investors at ACADIA Pharmaceuticals.

Who are the major institutional investors of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals' top institutional shareholders include:
  1. BlackRock Inc. — 6.13%
  2. State Street Corp — 3.31%
  3. Geode Capital Management LLC — 1.52%
  4. Goldman Sachs Group Inc. — 0.78%
  5. Jupiter Asset Management Ltd. — 0.78%
  6. Northern Trust Corp — 0.71%
Learn More about top institutional investors of ACADIA Pharmaceuticals stock.

Which institutional investors are selling ACADIA Pharmaceuticals stock?

In the last quarter, ACAD stock was sold by these institutional investors:
  1. JPMorgan Chase & Co.
  2. State Street Corp
  3. SG Americas Securities LLC
  4. Citigroup Inc.
  5. Jupiter Asset Management Ltd.
  6. Rockefeller Capital Management L.P.
  7. PDT Partners LLC
  8. International Biotechnology Trust PLC
During the previous year, company insiders that have sold ACADIA Pharmaceuticals company stock include:
  1. Bros Advisors Lp Baker (Director)
  2. Stephen Davis (CEO)
  3. Srdjan R Stankovic (President)
  4. Austin D Kim (EVP)
  5. Brendan Teehan (COO)
  6. Mark C Schneyer (CFO)
  7. Laura Brege (Director)
Learn More investors selling ACADIA Pharmaceuticals stock.

Which institutional investors are buying ACADIA Pharmaceuticals stock?

During the previous quarter, ACAD stock was purchased by institutional investors including:
  1. Woodline Partners LP
  2. Goldman Sachs Group Inc.
  3. Point72 Asset Management L.P.
  4. Penn Capital Management Company LLC
  5. BlackRock Inc.
  6. Nuveen Asset Management LLC
  7. Nuveen Asset Management LLC
  8. Frontier Capital Management Co. LLC
Free Stock Analysis Report: Buy Sell Hold Predictions on Any Stock
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Analyze Any Stock Free